Onderzoeker
Guy Laureys
- Trefwoorden:autoimmuniteit, multiple sclerose, neuroinflammatie, Immunologie, Neurologie
- Disciplines:Neurowetenschappen niet elders geclassificeerd, Inflammatie, Auto-immuniteit
Affiliaties
- Vakgroep Hoofd en Huid (Departement)
Lid
Vanaf1 okt 2019 → Heden
Projecten
1 - 3 of 3
- Charcot Stichting: Research Fund 2019Vanaf1 jan 2022 → 30 sep 2022Financiering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
- ”plug-and-play” design-methodologie voor medische plakkers voor sensorenVanaf1 apr 2020 → 31 dec 2023Financiering: VLAIO - Personalised Medicine ICON
- Preklinische evaluatie van nervus vagus stimulatie als therapeutische mogelijkheid voor multiple sclerose.Vanaf1 nov 2019 → 30 sep 2022Financiering: FWO Strategische Onderzoeksbeurs
Publicaties
1 - 10 van 47
- Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis : recruitment challenges, potential bias, and statistical strategies(2024)
Auteurs: Ying Li, Alice Saul, Bruce Taylor, Anne-Louise Ponsonby, Steve Simpson-Yap, Leigh Blizzard, Simon Broadley, Jeannette Lechner-Scott, Rana Karabudak, Francesco Patti, et al.
Pagina's: 472 - 485 - Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis(2023)
Auteurs: Tomas Kalincik, Sifat Sharmin, Mark S. Freedman, Harold Atkins, Joachim Burman, Jennifer Massey, Ian Sutton, Barbara Withers, Richard Macdonell, Andrew Grigg, et al.
Pagina's: 702 - 713 - Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis(2023)
Auteurs: Ibrahima Diouf, Charles B. Malpas, Sifat Sharmin, Izanne Roos, Dana Horakova, Eva Kubala Havrdova, Francesco Patti, Vahid Shaygannejad, Serkan Ozakbas, Guillermo Izquierdo, et al.
Pagina's: 1014 - 1024 - Exome sequencing and multigene panel testing in 1,411 patients with adult-onset neurologic disorders(2023)
Auteurs: Nika Schuermans, Hannah Verdin, Jody Ghijsels, Madeleine Hellemans, Elke Debackere, Elke Bogaert, Sofie Symoens, Leslie Naesens, Elien Lecomte, David Crosiers, et al.
- The risk of secondary progressive multiple sclerosis is geographically determined but modifiable(2023)
Auteurs: Sifat Sharmin, Izanne Roos, Steve Simpson-Yap, Charles Malpas, Marina M Sánchez, Serkan Ozakbas, Dana Horakova, Eva K Havrdova, Francesco Patti, Raed Alroughani, et al.
Pagina's: 4633 - 4644 - Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis(2023)
Auteurs: C Daruwalla, V Shaygannejad, S Ozakbas, EK Havrdova, D Horakova, R Alroughani, C Boz, F Patti, M Onofrj, A Lugaresi, et al.
Pagina's: 875 - 883 - Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis(2023)
Auteurs: Izanne Roos, Stella Hughes, Gavin McDonnell, Charles B. Malpas, Sifat Sharmin, Cavit Boz, Raed Alroughani, Serkan Ozakbas, Katherine Buzzard, Olga Skibina, et al.
Pagina's: 789 - 797 - Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation(2023)
Auteurs: Chao Zhu, Tomas Kalincik, Dana Horakova, Zhen Zhou, Katherine Buzzard, Olga Skibina, Raed Alroughani, Guillermo Izquierdo, Sara Eichau, Jens Kuhle, et al.
Pagina's: 739 - 748 - A unique phenotype of longitudinal extensive transverse myelitis in autoimmune lymphoproliferative syndrome(2022)
Auteurs: Cathérine Dekeyser, Leslie Naesens, Ciel De Vriendt, Alexander Schauwvlieghe, Guy Laureys
- Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity : the Belgian experience(2021)
Auteurs: Marie D’hooghe, Barbara Willekens, Valerie Delvaux, Miguel D’haeseleer, Daniel Guillaume, Guy Laureys, Guy Nagels, Patrick Vanderdonckt, Vincent Van Pesch, Veronica Popescu